$2.7B
$1.74 Million
0.01% of portfolio
422,521
Q4 2023
Added 13.46%
$10.2B
$4.01 Million
0.01% of portfolio
59,919
Q3 2024
New
$12.6B
$2.1 Million
0.01% of portfolio
266,631
Q3 2024
Added 13.16%
$3.88B
$3.07 Million
0.01% of portfolio
184,097
Q3 2024
Reduced 2.74%
$1.53B
$1.91 Million
0.01% of portfolio
65,875
Q3 2024
Reduced 1.56%
$1.49B
$3.37 Million
0.01% of portfolio
8,101
Q3 2024
Added 23.64%
$17.7B
$2.3 Million
0.01% of portfolio
49,025
Q3 2024
Reduced 65.01%
$44.6B
$2.62 Million
0.01% of portfolio
17,734
Q3 2024
Added 58.51%
$24B
$2.58 Million
0.01% of portfolio
5,904
Q3 2024
Added 378.83%
$20.3B
$2.6 Million
0.01% of portfolio
215,339
Q3 2024
Added 8,182.27%
$3.26B
$4.07 Million
0.01% of portfolio
76,907
Q3 2024
Added 2.29%
$12.1B
$4.26 Million
0.01% of portfolio
24,104
Q3 2024
New
$52.7B
$4 Million
0.01% of portfolio
36,514
Q3 2024
Reduced 14.79%
$14.1B
$3.58 Million
0.01% of portfolio
28,938
Q3 2024
Added 13.67%
$4.42B
$4.07 Million
0.01% of portfolio
88,352
Q3 2024
Reduced 2.54%
$3.08B
$2 Million
0.01% of portfolio
57,400
Q3 2024
New
$21.1B
$1.78 Million
0.01% of portfolio
4,566
Q3 2024
Reduced 52.26%
$1.29B
$2.54 Million
0.01% of portfolio
449,646
Q3 2024
Added 21.53%
$1.58B
$1.96 Million
0.01% of portfolio
73,423
Q3 2024
New
$3.26B
$4.26 Million
0.01% of portfolio
125,102
Q3 2024
Added 681.4%
$22.8B
$3.62 Million
0.01% of portfolio
19,062
Q3 2024
Reduced 0.4%
$28.7B
$3.61 Million
0.01% of portfolio
108,470
Q3 2024
Reduced 4.19%
$2.95B
$2.9 Million
0.01% of portfolio
112,770
Q3 2024
Reduced 8.52%
$2.6B
$3.39 Million
0.01% of portfolio
53,499
Q3 2024
Added 0.03%
$37.8B
$3.94 Million
0.01% of portfolio
21,649
Q3 2024
Added 123.76%
$25.3B
$1.8 Million
0.01% of portfolio
217,788
Q3 2024
Added 8.78%
$5.65B
$4.17 Million
0.01% of portfolio
20,142
Q3 2024
Reduced 1.56%
$8.02B
$4.49 Million
0.01% of portfolio
21,412
Q3 2024
Reduced 16.17%
$5.72B
$4.02 Million
0.01% of portfolio
37,545
Q3 2024
Reduced 13.35%
$14.1B
$2.44 Million
0.01% of portfolio
15,720
Q3 2024
Added 2.78%
$11.6B
$3.14 Million
0.01% of portfolio
50,406
Q3 2024
Reduced 51.8%
$48.1M
$2.06 Million
0.01% of portfolio
3,076,941
Q3 2024
Added 0.03%
$36.8B
$3.93 Million
0.01% of portfolio
60,223
Q3 2024
Added 54.18%
$1.33B
$4.51 Million
0.01% of portfolio
434,138
Q3 2024
Reduced 39.93%
$2.81B
$3.68 Million
0.01% of portfolio
105,073
Q3 2024
New
$2.54B
$4.75 Million
0.01% of portfolio
97,617
Q3 2024
Added 3.66%
$8.66B
$1.95 Million
0.01% of portfolio
41,330
Q3 2024
Reduced 44.17%
$21.8B
$3.31 Million
0.01% of portfolio
47,444
Q3 2024
Reduced 14.8%
$1.43B
$466,000
0.0% of portfolio
32,333
Q3 2024
New
$4.1B
$518,000
0.0% of portfolio
8,182
Q3 2024
New
$7.35B
$649,000
0.0% of portfolio
32,385
Q3 2024
Reduced 3.35%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 8.44%
$9.29B
$1.37 Million
0.0% of portfolio
30,367
Q2 2024
Added 106.58%
$9.86B
$897,000
0.0% of portfolio
9,477
Q3 2024
Reduced 43.45%
$3.01B
$176,000
0.0% of portfolio
32,404
Q3 2024
Reduced 4.99%
$17.1B
$502,000
0.0% of portfolio
1,973
Q3 2024
Reduced 81.11%
$11.7B
$523,000
0.0% of portfolio
14,706
Q3 2024
Added 10.79%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 54.55%
$3.17B
$347,000
0.0% of portfolio
1,471
Q3 2024
Reduced 29.52%
$760M
$69,000
0.0% of portfolio
28,200
Q2 2024
Reduced 72.13%